Patient info

Exemestane 25 mg film-coated tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
25 mg
Contains active substance:
ATC code:
Similar medicines:

Patient leaflet - Exemestane 25 mg film-coated tablets

1. WHAT EXEMESTANE IS AND WHAT IT IS USED FOR

Your medicine is called Exemestane. Exemestane belongs to a group of medicines known as aromatase inhibitors. These drugs interfere with a substance called aromatase, which is needed to make the female sex hormone, oestrogen, especially in postmenopausal women. Reducing oestrogen levels in the body is a way of treating hormone-dependent breast cancer.

Exemestane is used to treat hormone-dependent early breast cancer in postmenopausal women after they have completed 2-3 years of treatment with the medicine tamoxifen.

It is also used to treat hormone-dependent advanced breast cancer in postmenopausal women when a different hormonal drug treatment has not worked well enough.

2. BEFORE YOU TAKE EXEMESTANE

Do not take Exemestane

  • if you are or have previously been allergic

    (hypersensitive) to exemestane (the active ingredient in Exemestane or any of the other ingredients of Exemestane (Please see section 6).

  • if you have not already been through ‘the menopause’,

    i.e. you are still having your monthly period,

  • if you are pregnant, likely to be pregnant or

    breast-feeding.

Warnings and Precautions

  • Before treatment with Exemestane, your doctor may

    want to take blood samples to make sure you have reached the menopause.

  • Before taking Exemestane, tell your doctor if you have

    problems with your liver or kidneys.

  • If you have a history or are suffering from any

    condition which affects the strength of your bones. This is because drugs of this class lower the levels of female hormones and this may lead to a loss of the mineral content of bones, which might decrease their strength. You may have to undergo tests to measure your bone density before and during treatment. Your doctor can give you medicines or Vitamin D supplements to prevent or treat the bone loss.

    Taking other medicines

    Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

    Exemestane should not be given at the same time as hormone replacement therapy (HRT). The following medicines should be used cautiously when taking Exemestane. Let your doctor know if

    you are taking medicines such as:

    • rifampicin (an antibiotic),
    • carbamazepine or phenytoin (anti-convulsants used to treat epilepsy),
    • the herbal remedy St John’s wort (Hypericum perforatum), or preparations containing it. Pregnancy and breast-feeding

Do not take Exemestane if you are pregnant or breast-feeding.

If you are pregnant or think you might be, tell your doctor. Discuss contraception with your doctor if there is any possibility that you may become pregnant.

Driving and using machines

If you feel drowsy, dizzy or weak whilst taking Exemestane, you should not attempt to drive or operate machinery.

Exemestane contains sodium:

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

3. HOW TO TAKE EXEMESTANE

Always take Exemestane exactly as your doctor has told you. You should check with your doctor or pharmacist if you are unsure. Your doctor will tell you how to take Exemestane and for how long.

Adults and the elderly

The usual dose is one 25 mg film-coated tablet daily. Exemestane film-coated tablets should be taken by mouth after a meal at approximately the same time each day. Your doctor will tell you how to take Exemestane and for how long. Children and adolescents

Exemestane is not suitable for use in children and adolescents.

If you take more Exemestane than you should

If too many tablets are taken by accident, contact your doctor at once or go straight to the nearest hospital casualty department. Show them the pack of Exemestane film-coated tablets.

If you forget to take Exemestane

Do not take a double dose to make up for a forgotten dose. If you forget to take your film-coated tablet, take it as soon as you remember. If it is nearly time for the next dose, take it at the usual time.

If you stop taking Exemestane

Do not stop taking your film-coated tablets even if you are feeling well, unless your doctor tells you. If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4. POSSIBLE SIDE EFFECTS

Like all medicines, Exemestane can cause side effects, although not everybody gets them. Hypersensitivity, inflammation of the liver (hepatitis) and inflammation of the bile ducts of the liver which cause yellowing of the skin (cholestatic hepatitis) may occur. Symptoms include feeling generally unwell, nausea, jaundice (yellowing of the skin and eyes), itching, right sided abdominal pain and loss of appetite. Contact your doctor promptly to seek urgent medical advice if you think you have any of these symptoms.

NAP

NAP

NLT 40 GSM News print paper

NAP

NAP

NAP

LH : 160 mm x 240 mm Rudipharm Limited / UK

Back

Marketing Authorisation Holder:

Rudipharm Limited

Unit 6, Salbrook Road Industrial Estate

Salbrook Road, Redhill, Surrey, RH1 5GJ, United Kingdom

Manufacturer:

Rudipharm Limited

Oak House, Reeds Crescent,

Watford, WD24 4QP, UK

To listen to or request a copy of this leaflet in Braille, large print or audio please call, 01293 827819 (UK only)

Please be ready to give the following information:

Product name

Exemestane 25mg tablets

Reference number

PL 49565/0147

This leaflet was last revised in November 2025.

In general, Exemestane is well tolerated and the following side effects observed in patients treated with Exemestane are mainly mild or moderate in nature. Most of the side effects are associated with a shortage of oestrogen (e.g. hot flushes).

Very common side effects, (ocurring in more than 1 in 10 people):

  • Difficulty sleeping
  • Headache
  • Hot flushes
  • dizziness
  • Feeling sick
  • Increased sweating
  • Muscle and joint pain (including osteoarthritis, back

    pain, arthritis and joint stiffness)

  • Tiredness
  • Depression
  • Abdominal Pain
  • A reduction in the number of white blood cells • Elevated level of liver enzymes
  • Elevated level of a haemoglobin breakdown in the

    blood

  • Elevated level of a blood enzyme in the blood due to

    liver damage

  • Pain

Common side effects, (occuring in more than 1 in 100 but less than 1 in 10 people):

  • Loss of appetite
  • carpal tunnel syndrome (a combinations of pins and

    needles, numbness and pain affecting all of the hand except the little finger) or tingling/prickling of the skin. • vomiting (being sick), constipation, indigestion, diarrhoea • Skin rash hives and itchiness

  • hair loss
  • Thinning of bones which might decrease their strength

    (osteoporosis), leading to bone fractures (breaks or cracks) in some cases

  • swollen hands and feet
  • A reduction in the number of platelets in the blood • Feeling of weakness

Uncommon side effects, (occurring in more than 1 in 1000 but less than 1 in 100 people):

  • Hypersensitivity

Rare: may affect up to 1 in 1,000 people

  • A breakout of small blisters on an area of the skin in a

    rash

  • Drowsiness
  • Inflammation of the liver
  • Inflammation of the bile ducts of the liver which cause

    yellowing of the skin

Not known: frequency cannot be estimated from the available data

  • Low level of certain white blood cells in the blood Changes in the amount of certain blood cells (lymphocytes) and platelets (blood cells which cause clotting) circulating in your blood may occur, especially in patients with a pre-existing lymphopenia (reduced lymphocytes in the blood).

If any side effects gets serious or if you notice any side effect not listed on this leaflet, please tell your doctor or your pharmacist as soon as possible.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA

Yellow Card in the Google Play or Apple App Store. By reporting side-effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE EXEMESTANE

Keep out of the reach and sight of children.

Do not use Exemestane after the expiry date which is stated on the carton after <EXP>.

The expiry date refers to the last day of that month. This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. FURTHER INFORMATION

What Exemestane contains

The active substance is exemestane. Each film coated tablet contains 25 mg exemestane.

The other ingredients are:

Tablet core:

Mannitol, Copovidone, Crospovidone, Microcrystalline Cellulose, Silica, colloidal anhydrous Sodium Starch Glycolate (Type A), Magnesium Stearate

Film coating:

Hypromellose, Macrogol 400,Titanium Dioxide.

What Exemestane looks like and contents of the pack

White to off-white, round compound cup tablet, with “25” on one side and plain on the reverse.

Exemestane is available in blister packs of:

15, 20, 30, 90, 100, 120 and 200 (Blisters of 10 & 15) film-coated tablets.

Not all pack sizes may be marketed.

Exemestane 25 mg Tablets

Headings: 11pt (Bold)

Sub-Heading: 9pt (Bold)

Normal Text: 9pt (Regular)

Exemestane 25mg tablets - PIL

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 49565/0147

Last revision stated in the text: November 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Exemestane 25 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Exemestane
Strength 25 mg
Pharmaceutical form Oral tablet
White to off-white, round compound cup film coated tablet, with “25” on one side and plain on the reverse.
How is it taken Oral
Excipients Mannitol (E421), Copovidone, Crospovidone, Microcrystalline Cellulose, Silica, colloidal anhydrous, Sodium Starch Glycolate (Type A), Magnesium Stearate(E470b), Hypromellose (E464), Macrogol 400, Titanium Dioxide(E171)
Pack sizes 30 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Hormone antagonists and related agents, enzyme inhibitors
  1. L Antineoplastic and immunomodulating agents
    1. L02 Endocrine therapy antineoplastic and immunomodulating agents
      1. L02B Hormone antagonists and related agents
        1. L02BG Aromatase inhibitors
          1. L02BG06 exemestane
Marketing authorisation PL 49565/0147 (first authorised 25 September 2025), PL 56284/0038 (first authorised 25 February 2025)
Marketing authorisation holder Rudipharm Limited, Eugia (UK) Limited
Codes GTIN 5060705240939 · BNF 08030401

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.